Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALFA-1
NCT02584582Phase 3Unknown
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- Jul 2015
- Primary completion
- Nov 2015
- Modality
- Peptides
01
Overview
A Phase 3 trial of liraglutide, exenatide in type 1 diabetes mellitus (T1D), sponsored by Copenhagen University Hospital - Hvidovre. Status: unknown.
02
Drugs
liraglutideexenatide
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02584582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02584582.